EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Material-aware preclinical digital twins for breast cancer: engineered matrices as causal and auditable interfaces

Longzhu Nie, Songjie Shen

Frontiers in Bioengineering and Biotechnology · 11.11.2026 · 14

DOI: 10.3389/fbioe.2026.2011607 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 11.11.2026. Verfasst von Longzhu Nie und 1 weiteren Autor:innen. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Imaging-calibrated breast cancer digital twins have retrospectively forecast treatment response in selected longitudinal imaging cohorts. Patient-derived (patient-sourced) organoids, tunable hydrogels, bioprinted tissues, and tumor-on-chip platforms now reproduce selected features of the tumor microenvironment. We propose integrating these components into a closed-loop architecture that has not been prospectively validated as a complete system in breast cancer. The missing interface is a material layer in which extracellular-matrix chemistry, mechanics, architecture, transport, remodeling, and spatial heterogeneity are measured and perturbed as model variables. The synchronized physical referent is a versioned ensemble of engineered tumor constructs. Patient -conditioned computational states are initialized or constrained by individual-patient observations, while construct measurements govern the experimental state. Uncertainty-aware algorithms select feasible perturbations to distinguish mechanisms or reduce predictive uncertainty; batch metrology and biological phenotypes update or falsify the computational counterpart. Biomaterials thereby serve as experimental actuators, measurement interfaces, and reproducible benchmark conditions. We specify twin identity and synchronization, a five-level validation ladder from material validity to health-system readiness, and a staged translational pathway. Biological incompleteness, coupled material properties, limited tissue, and uncertain transfer from constructs to patients constrain near-term use. The opportunity is a reproducible preclinical learning system with explicit validation gates before patient-level claims. Its predictions remain useful only when a physical experiment can refute them.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Nie, L., & Shen, S. (2026). Material-aware preclinical digital twins for breast cancer: engineered matrices as causal and auditable interfaces. Frontiers in Bioengineering and Biotechnology, 14. https://doi.org/10.3389/fbioe.2026.2011607

Vancouver

Nie L, Shen S. Material-aware preclinical digital twins for breast cancer: engineered matrices as causal and auditable interfaces. Frontiers in Bioengineering and Biotechnology. 2026;14. doi:10.3389/fbioe.2026.2011607

BibTeX
@article{Nie2026,
  author = {Nie, Longzhu and Shen, Songjie},
  title = {Material-aware preclinical digital twins for breast cancer: engineered matrices as causal and auditable interfaces},
  journal = {Frontiers in Bioengineering and Biotechnology},
  year = {2026},
  volume = {14},
  doi = {10.3389/fbioe.2026.2011607}
}
Kostenlos starten →